Elevage Medical Technologies

Elevage Medical Technologies does not develop its own products but provides capital and expertise to growth-stage medical technology/device companies. It supports these companies from advanced clinical development through commercialization. Notable investments include FIRE1 (heart failure management) and Elucid (Series C round), among others. No direct clinical results attributable to Elevage itself. "Elevage provides capital along with deep technical, regulatory, and operational expertise to companies ranging from advanced clinical development to commercial acceleration stage." "Elevage supports rapidly growing, highly differentiated companies with paradigm shifting technologies..."